ARYx Therapeutics Inc (ARYX.PK)

ARYX.PK on OTC Markets Group

0.01USD
19 Aug 2014
Price Change (% chg)

-- (+6.67%)
Prev Close
$0.01
Open
$0.01
Day's High
$0.01
Day's Low
$0.01
Volume
50,000
Avg. Vol
15,053
52-wk High
$0.05
52-wk Low
$0.01

ARYX.PK

Chart for ARYX.PK

About

ARYx Therapeutics, Inc. is a United States-based pharmaceutical Company. The Company is developing a proprietary portfolio of patient-targeted, first-in-class monoclonal antibodies designed to treat seriously ill patients with difficult-to-treat diseases. It is engaged in retrometabolic drug design that focuses on the safety of... (more)
No analyst recommendations are available for ARYX.PK.

Overall

Beta: 0.10
Market Cap (Mil.): $0.25
Shares Outstanding (Mil.): 33.46
Dividend: --
Yield (%): --

Financials

  ARYX.PK Industry Sector
P/E (TTM): -- 32.75 33.57
EPS (TTM): -0.61 -- --
ROI: -487.55 18.80 18.05
ROE: -- 19.44 18.79
Search Stocks

Competitors

  Price Change
Johnson & Johnson (JNJ.N) $102.96 +0.26
Pfizer Inc. (PFE.N) $28.94 +0.10
Novartis AG (NOVN.VX) CHF80.30 +1.05
Sanofi SA (SASY.PA) €79.75 +0.13
AstraZeneca plc (AZN.L) 4,238.50p +37.00
Bayer AG (BAYGn.DE) €95.41 -2.28
Bayer AG (BAYE.F) -- --
3M Co (MMM.N) $144.25 +0.13
Bristol-Myers Squibb Co (BMY.N) $50.30 +0.31
Bristol-Myers Squibb Co (BMYMP.PK) $830.54 +9.12

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: S&P Capital IQ Quantitative Report
$104.00
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$250.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks